Shanghai Runda Medical Technology Co., Ltd. (603108.SS)
CNY 17.43
(0.87%)
CNY 17.43
(0.87%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.41 Billion CNY | -21.97% |
| 2022 | 2.93 Billion CNY | 22.8% |
| 2021 | 2.39 Billion CNY | 25.12% |
| 2020 | 1.91 Billion CNY | -0.19% |
| 2019 | 1.91 Billion CNY | 16.73% |
| 2018 | 1.64 Billion CNY | 34.94% |
| 2017 | 1.21 Billion CNY | 99.93% |
| 2016 | 608.19 Million CNY | 37.32% |
| 2015 | 442.9 Million CNY | 23.21% |
| 2014 | 359.46 Million CNY | 24.41% |
| 2013 | 288.93 Million CNY | 25.81% |
| 2012 | 229.65 Million CNY | 3.83% |
| 2011 | 221.18 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 543.89 Million CNY | -11.28% |
| 2024 Q2 | 565.26 Million CNY | 3.93% |
| 2024 Q3 | 454.03 Million CNY | -19.68% |
| 2023 Q3 | 559.95 Million CNY | -11.53% |
| 2023 Q4 | 613.07 Million CNY | 9.49% |
| 2023 FY | 2.29 Billion CNY | -21.97% |
| 2023 Q1 | 587.57 Million CNY | -37.56% |
| 2023 Q2 | 632.96 Million CNY | 7.72% |
| 2022 Q2 | 653.48 Million CNY | 19.83% |
| 2022 Q1 | 545.34 Million CNY | -9.88% |
| 2022 FY | 2.93 Billion CNY | 22.8% |
| 2022 Q4 | 940.96 Million CNY | 17.98% |
| 2022 Q3 | 797.56 Million CNY | 22.05% |
| 2021 Q2 | 621.18 Million CNY | 15.77% |
| 2021 Q4 | 605.09 Million CNY | -3.82% |
| 2021 Q3 | 629.15 Million CNY | 1.28% |
| 2021 FY | 2.39 Billion CNY | 25.12% |
| 2021 Q1 | 536.57 Million CNY | -17.97% |
| 2020 Q3 | 534.27 Million CNY | 24.43% |
| 2020 FY | 1.91 Billion CNY | -0.19% |
| 2020 Q4 | 654.14 Million CNY | 22.44% |
| 2020 Q2 | 429.37 Million CNY | 46.08% |
| 2020 Q1 | 293.92 Million CNY | -45.67% |
| 2019 Q2 | 472.24 Million CNY | 19.2% |
| 2019 Q1 | 396.17 Million CNY | -12.67% |
| 2019 FY | 1.91 Billion CNY | 16.73% |
| 2019 Q4 | 541.05 Million CNY | 6.95% |
| 2019 Q3 | 505.87 Million CNY | 7.12% |
| 2018 Q1 | 347.22 Million CNY | -13.0% |
| 2018 FY | 1.64 Billion CNY | 34.94% |
| 2018 Q3 | 434.83 Million CNY | 7.33% |
| 2018 Q2 | 405.12 Million CNY | 16.67% |
| 2018 Q4 | 453.67 Million CNY | 4.33% |
| 2017 Q3 | 327.27 Million CNY | 15.77% |
| 2017 FY | 1.21 Billion CNY | 99.93% |
| 2017 Q4 | 399.12 Million CNY | 21.95% |
| 2017 Q1 | 206.88 Million CNY | -5.59% |
| 2017 Q2 | 282.68 Million CNY | 36.64% |
| 2016 Q4 | 219.13 Million CNY | 38.5% |
| 2016 Q1 | 101.74 Million CNY | -29.33% |
| 2016 Q3 | 158.22 Million CNY | 22.57% |
| 2016 FY | 608.19 Million CNY | 37.32% |
| 2016 Q2 | 129.08 Million CNY | 26.87% |
| 2015 Q2 | 105.73 Million CNY | 27.12% |
| 2015 FY | 442.9 Million CNY | 23.21% |
| 2015 Q4 | 143.96 Million CNY | 30.85% |
| 2015 Q3 | 110.02 Million CNY | 4.06% |
| 2015 Q1 | 83.17 Million CNY | -34.34% |
| 2014 Q4 | 126.68 Million CNY | 50.16% |
| 2014 Q2 | 114 Million CNY | 83.32% |
| 2014 Q3 | 84.36 Million CNY | -25.99% |
| 2014 FY | 359.46 Million CNY | 24.41% |
| 2014 Q1 | 62.18 Million CNY | 0.0% |
| 2013 FY | 288.93 Million CNY | 25.81% |
| 2012 FY | 229.65 Million CNY | 3.83% |
| 2011 FY | 221.18 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Joinn Laboratories(China)Co.,Ltd. | 1.01 Billion CNY | -138.808% |
| WuXi AppTec Co., Ltd. | 16.27 Billion CNY | 85.141% |
| Autobio Diagnostics Co., Ltd. | 2.83 Billion CNY | 14.593% |
| Thalys Medical Technology Group Inc. | 389.73 Million CNY | -520.577% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 3.11 Billion CNY | 22.358% |
| Chemclin Diagnostics Co., Ltd. | 335.61 Million CNY | -620.645% |